Molecular interplay between microRNA-34a and sirtuin1 in hyperglycemia-mediated impaired angiogenesis in endothelial cells: Effects of metformins

Journal of Pharmacology and Experimental Therapeutics

Volumn 356, Issue 2, 2016, Pages 314-323

  Arunachalam, Gnanapragasam ^a   Lakshmanan, Arun Prasath ^a   Samuel, Samson Mathews ^a   Triggle, Chris R ^a   Ding, Hong ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; METFORMIN; MICRORNA 34A; SIRTUIN 1; ANTIDIABETIC AGENT; MICRORNA; MIRN34 MICRORNA, MOUSE;

ACETYLATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERGLYCEMIA; IMMUNOBLOTTING; MOLECULAR INTERACTION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RADIOIMMUNOPRECIPITATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM; MICROVASCULATURE; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; METFORMIN; MICE; MICRORNAS; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; SIRTUIN 1; TREATMENT OUTCOME;

EID: 84959420544     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.115.226894     Document Type: Article

References (60)

1. Arunachalam G, Samuel SM, Marei I, Ding H, and Triggle CR (2014) Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. Br J Pharmacol 171: 523-535.
2. Arunachalam G, Upadhyay R, Ding H, and Triggle CR (2015) MicroRNA signature and cardiovascular dysfunction. J Cardiovasc Pharmacol 65: 419-429.
3. Arunachalam G, Yao H, Sundar IK, Caito S, and Rahman I (2010) SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol. Biochem Biophys Res Commun 393: 66-72.
4. Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, and Fadini GP (2011) Endothelial dysfunction in diabetes: The role of reparatory mechanisms. Diabetes Care 34 (Suppl 2): S285-S290.
5. Badi I, Burba I, Ruggeri C, Zeni F, Bertolotti M, and Scopece A, et al. (2015) MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors. J Gerontol A Biol Sci Med Sci 70: 1304-1311.
6. Beltrami C, Angelini TG, and Emanueli C (2014) Noncoding RNAs in diabetes vascular complications. J Mol Cell Cardiol DOI: 10.1124/pr.55.3.4 [published ahead of print].
7. Blandino G, Valerio M, Cioce M, Mori F, Casadei L, Pulito C, Sacconi A, Biagioni F, Cortese G, and Galanti S, et al. (2012) Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. Nat Commun 3: 865.
8. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Tréguer K, Carmona G, and Bonauer A, et al. (2013) MicroRNA-34a regulates cardiac ageing and function. Nature 495: 107-110.
9. Caporali A, Meloni M, Völlenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, and Baker AH, et al. (2011) Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 123: 282-291.
10. Choi SE, Fu T, Seok S, Kim DH, Yu E, Lee KW, Kang Y, Li X, Kemper B, and Kemper JK (2013) Elevated microRNA-34a in obesity reduces NAD1 levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 12: 1062-1072.
11. Cui X, Chopp M, Zacharek A, Ye X, Roberts C, and Chen J (2011) Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis 43: 285-292.
12. Ding H and Triggle CR (2010) Endothelial dysfunction in diabetes: Multiple targets for treatment. Pflugers Arch 459: 977-994.
13. Ding J, Li M, Wan X, Jin X, Chen S, Yu C, and Li Y (2015) Effect of miR-34a in regulating steatosis by targeting PPARa expression in nonalcoholic fatty liver disease. Sci Rep 5: 13729.
14. D'Onofrio N, Vitiello M, Casale R, Servillo L, Giovane A, and Balestrieri ML (2015) Sirtuins in vascular diseases: Emerging roles and therapeutic potential. Biochim Biophys Acta 1852: 1311-1322.
15. Eelen G, de Zeeuw P, Simons M, and Carmeliet P (2015) Endothelial cell metabolism in normal and diseased vasculature. Circ Res 116: 1231-1244.
16. El-Mir MY, Nogueira V, Fontaine E, Avéret N, Rigoulet M, and Leverve X (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275: 223-228.
17. Fan W, Fang R, Wu X, Liu J, Feng M, Dai G, Chen G, and Wu G (2015) Shearsensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation. J Cell Sci 128: 70-80.
18. Foretz M, Guigas B, Bertrand L, Pollak M, and Viollet B (2014) Metformin: From mechanisms of action to therapies. Cell Metab 20: 953-966.
19. Fu T, Seok S, Choi S, Huang Z, Suino-Powell K, Xu HE, Kemper B, and Kemper JK (2014) MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol 34: 4130-4142.
20. Fukuhara S, Sako K, Noda K, Zhang J, Minami M, and Mochizuki N (2010) Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 25: 387-396.
21. Giacco F and Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107: 1058-1070.
22. Halimi S (2006) Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management. Diabetes Metab 32: 555-556.
23. Han H, Qu G, Han C, Wang Y, Sun T, Li F, Wang J, and Luo S (2015) MiR-34a, miR- 21 and miR-23a as potential biomarkers for coronary artery disease: A pilot microarray study and confirmation in a 32 patient cohort. Exp Mol Med 47: E138.
24. Hata A (2013) Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol 75: 69-93.
25. Ito T, Yagi S, and Yamakuchi M (2010) MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 398: 735-740.
26. Kinaan M, Ding H, and Triggle CR (2015) Metformin: An old drug for the treatment of diabetes but a new drug for the protection of the endothelium. Med Princ Pract 24: 401-415.
27. Kolluru GK, Bir SC, and Kevil CG (2012) Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012: 1-30.
28. Leeper NJ and Cooke JP (2011) MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus. Circulation 123: 236-238.
29. Li X, Khanna A, Li N, and Wang E (2011) Circulatory miR34a as an RNA based, noninvasive biomarker for brain aging. Aging 3: 985-1002.
30. Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, and MacDonald MJ, et al. (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510: 542-546.
31. Mather KJ, Verma S, and Anderson TJ (2001) Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 37: 1344-1350.
32. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, and Irani K (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 104: 14855-14860.
33. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, and Clementi E, et al. (2005) Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310: 314-317.
34. Olson EN (2014) MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med 6: 239ps3.
35. Orimo M, Minamino T, Miyauchi H, Tateno K, Okada S, Moriya J, and Komuro I (2009) Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol 29: 889-894.
36. Owen MR, Doran E, and Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348: 607-614.
37. Pannirselvam M, Verma S, Anderson TJ, and Triggle CR (2002) Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: Role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136: 255-263.
38. Potente M and Dimmeler S (2008) Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7: 2117-2122.
39. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, and Alt FW, et al. (2007) SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21: 2644-2658.
40. Qin B, Yang H, and Xiao B (2012) Role of microRNAs in endothelial inflammation and senescence. Mol Biol Rep 39: 4509-4518.
41. Roberts AC and Porter KE (2013) Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diab Vasc Dis Res 10: 472-482.
42. Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, and Ido Y (2010) AMPK and SIRT1: A long-standing partnership? Am J Physiol Endocrinol Metab 298: E751-E760.
43. Semeniuk LM, Kryski AJ, and Severson DL (2002) Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol 283: H976-H982.
44. Sena CM, Matafome P, Louro T, Nunes E, Fernandes R, and Seiça RM (2011) Metformin restores endothelial function in aorta of diabetic rats. Br J Pharmacol 163: 424-437.
45. Sena CM, Pereira AM, and Seiça R (2013) Endothelial dysfunction: A major mediator of diabetic vascular disease. Biochim Biophys Acta 1832: 2216-2231.
46. Staszel T, Zapala B, Polus A, Sadakierska-Chudy A, Kiec-Wilk B, Stepien E, Wybranska I, Chojnacka M, and Dembinska-Kiec A (2011) Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 121: 361-366.
47. Suárez Y and Sessa WC (2009) MicroRNAs as novel regulators of angiogenesis. Circ Res 104: 442-454.
48. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, and Yancopoulos GD (1998) Increased vascularization in mice overexpressing angiopoietin-1. Science 282: 468-471.
49. Tabuchi T, Satoh M, Itoh T, and Nakamura M (2012) MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: Effect of statins on SIRT1 and microRNA-34a expression. Clin Sci 123: 161-171.
50. Tremblay J and Hamet P (2015) Biomarkers of vascular complications in type 2 diabetes. Metabolism 64(Suppl 1): S28-S32.
51. Triggle CR and Ding H (2014) Cardiovascular impact of drugs used in the treatment of diabetes. Ther Adv Chronic Dis 5: 245-268.
52. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703-713.
53. Urbich C, Kuehbacher A, and Dimmeler S (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588.
54. Yamakuchi M, Ferlito M, and Lowenstein CJ (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105: 13421-13426.
55. Yang Y, Cheng HW, Qiu Y, Dupee D, Noonan M, Lin YD, Fisch S, Unno K, Sereti KI, and Liao R (2015) MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circ Res 117: 450-459.
56. Zampetaki A and Mayr M (2012) MicroRNAs in vascular and metabolic disease. Circ Res 110: 508-522.
57. Zhang TX, Xu JX, Peng F, Chai DJ, and Lin JX (2013) Metformin reduces vascular endothelial dysfunction caused by an acute glucose load in patients with hypertension. Blood Press 22: 106-113.
58. Zhao T, Li J, and Chen AF (2010) MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 299: E110-E116.
59. Zheng Z, Chen H, Li J, Li T, Zheng B, Zheng Y, Jin H, He Y, Gu Q, and Xu X (2012) Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/ AMPK/ROS pathway and therapeutic effects of metformin. Diabetes 61: 217-228.
60. Zhu H and Leung SW (2015) Identification of microRNA biomarkers in type 2 diabetes: A meta-analysis of controlled profiling studies. Diabetologia 58: 900-911.